JCRB1554 MMNK-1
Cell information
Important Notice(s)This cell line is available for only academic users.
Articles regarding TMNK-1 / TWNT-1 / MMNK-1
Cell type:genetically-modified cells (View Pricing Information)
JCRB No. | JCRB1554 | Cell Name | MMNK-1 |
---|---|---|---|
Profile | Highly differentiated immortalized human cholangiocyte cell line. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | Age | ||
Identity | available | Tissue for Primary Cancer | |
Case history | Metastasis | No | |
Tissue Metastasized | Genetics | Expressing catalytic subunit of human telomerase reverse transcriptase (hTERT) and enhanced green fluorescent protein (EGFP). | |
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | |
Classify | transformed | Established by | Kobayashi, N. |
Registered by | Mochitate, K. | Regulation for Distribution | [Maruyama et al. Transplantation 77: 446-451, 2004] should be cited at the paper submission. |
Comment | The distribution is limieted to academic Japan domestic users and academic oversea users. The following reference should be cited at the publication of paper. Maruyama et al. Transplantation 77: 446-451, 2004. | Year | 2013 |
Medium | DMEM with 5% fetal bovine serum | Methods for Passages | Cells were harvested after treatment with Accutase and split ratio(1/3-1/4) |
Cell Number on Passage | Race | ||
CO2 Conc. | 5% | Tissue Sampling | |
Tissue Type | cholangiocytes (OUMS-21) |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:14966424 | Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT. Maruyama M,Kobayashi N,Westerman KA,Sakaguchi M,Allain JE,Totsugawa T,Okitsu T,Fukazawa T,Weber A,Stolz DB,Leboulch P,Tanaka N Transplantation. 2004 Feb 15;77(3):446-51 |
Images |
---|
Movies |
---|
LOT Information
Cell No. | JCRB1554 | Cell Name | MMNK-1 |
---|---|---|---|
LOT No. | 09142013 | Lot Specification | distribution |
Medium | DMEM with 5% fetal bovine serum(SIGMA027K03911,non HI) | Temperature | 37 C |
Cell Density at Seeding | 0.4-1.5x10^5 cells/sq.cm | Methods for Passages | Cells were harvested after treatment with Accutase and split ratio(1/3-1/4) |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.15x10^6 |
Viability at cell freezing (%) | 97.0 | Antibiotics Used | free |
Passage Number | p4* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | D5S818:11,15 D13S317:9,12 D7S820:8,9 D16S539:11,13 VWA:14,17 TH01:7,9 AM:X TPOX:8,11 CSF1PO:11,12 |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | Cell Banker BLC-1(Nihon Zenyaku Industries) | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB1554 | Cell Name | MMNK-1 |
---|---|---|---|
LOT No. | 02022017 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 5% fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
Cell Density at Seeding | 5.3 - 6.3 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with Accutase. |
Doubling Time | approx. 32 hrs | Cell Number in Vial (cells/1ml) | 1.2 x 10^6 |
Viability at cell freezing (%) | 84.9 | Antibiotics Used | free |
Passage Number | Unknown (7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 84.9 | Additional information |
Cell No. | JCRB1554 | Cell Name | MMNK-1 |
---|---|---|---|
LOT No. | 05162019 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 5% fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
Cell Density at Seeding | 0.3 - 1.3 x 10^5 cells/mL | Methods for Passages | Cells were harvested after treatment with Accutase. |
Doubling Time | approx. 26 hrs. | Cell Number in Vial (cells/1ml) | 2.2 x 10^6 |
Viability at cell freezing (%) | 96.9 | Antibiotics Used | free |
Passage Number | Unknown (8 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 90.9 | Additional information |
Cell No. | JCRB1554 | Cell Name | MMNK-1 |
---|---|---|---|
LOT No. | 07042024 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium with 5% fetal bovine serum (FBS; Nichirei Cat. # 174112, Lot 20M00K) | Temperature | 37 C |
Cell Density at Seeding | 1.6 - 3.1 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with accutase. |
Doubling Time | 20 - 30 hrs | Cell Number in Vial (cells/1ml) | 1.4 x 10^6 |
Viability at cell freezing (%) | 93.7 | Antibiotics Used | free |
Passage Number | Unknown (7 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - DMEM | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 83.8 | Additional information |